BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12667113)

  • 21. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol.
    Peyron R; Aubény E; Targosz V; Silvestre L; Renault M; Elkik F; Leclerc P; Ulmann A; Baulieu EE
    N Engl J Med; 1993 May; 328(21):1509-13. PubMed ID: 8479487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induced abortion: an overview for internists.
    Grimes DA; Creinin MD
    Ann Intern Med; 2004 Apr; 140(8):620-6. PubMed ID: 15096333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medications Used in Evidence-Based Regimens for Medical Abortion: An Overview.
    Soon JA; Costescu D; Guilbert E
    J Obstet Gynaecol Can; 2016 Jul; 38(7):636-45. PubMed ID: 27591347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acceptability of medical abortion with methotrexate and misoprostol.
    Creinin MD; Park M
    Contraception; 1995 Jul; 52(1):41-4. PubMed ID: 8521713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days.
    Schaff EA; Fielding SL; Eisinger SH; Stadalius LS; Fuller L
    Contraception; 2000 Jan; 61(1):41-6. PubMed ID: 10745068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost of goods sold analysis and recommendations to reduce costs of co-packaged mifepristone-misoprostol for medical abortion.
    Chinery L; Allaouidine C; Tomazzini A; Larson M; Gülmezoglu AM
    Reprod Health; 2020 Nov; 17(1):171. PubMed ID: 33148282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-surgical abortion: who's for methotrexate?
    Potts M
    Lancet; 1995 Sep; 346(8976):655-6. PubMed ID: 7658816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical abortion in early pregnancy: a review of the evidence.
    Grimes DA
    Obstet Gynecol; 1997 May; 89(5 Pt 1):790-6. PubMed ID: 9166323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486).
    el-Refaey H; Hinshaw K; Templeton A
    Hum Reprod; 1993 Oct; 8(10):1744-6. PubMed ID: 8300840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy, Safety, and Acceptability of Low-Dose Mifepristone and Self-Administered Misoprostol for Ultra-Early Medical Abortion: A Randomized Controlled Trial.
    Li CL; Song LP; Tang SY; Zhou LJGY; He H; Mo XT; Liao YM
    Reprod Sci; 2017 May; 24(5):731-737. PubMed ID: 27678099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alternatives to mifepristone for early medical abortion.
    Moreno-Ruiz NL; Borgatta L; Yanow S; Kapp N; Wiebe ER; Winikoff B
    Int J Gynaecol Obstet; 2007 Mar; 96(3):212-8. PubMed ID: 17280669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days' LMP: a prospective comparative open-label trial.
    Bracken H; Dabash R; Tsertsvadze G; Posohova S; Shah M; Hajri S; Mundle S; Chelli H; Zeramdini D; Tsereteli T; Platais I; Winikoff B
    Contraception; 2014 Mar; 89(3):181-6. PubMed ID: 24332431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of mifepristone-buccal misoprostol for early medical abortion in an Australian clinical setting.
    Goldstone P; Walker C; Hawtin K
    Aust N Z J Obstet Gynaecol; 2017 Jun; 57(3):366-371. PubMed ID: 28303569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early pregnancy termination with mifepristone and misoprostol in the United States.
    Spitz IM; Bardin CW; Benton L; Robbins A
    N Engl J Med; 1998 Apr; 338(18):1241-7. PubMed ID: 9562577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abortion with mifepristone and misoprostol: regimens, efficacy, acceptability and future directions.
    Newhall EP; Winikoff B
    Am J Obstet Gynecol; 2000 Aug; 183(2 Suppl):S44-53. PubMed ID: 10944369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Termination of early pregnancy by two regimens of mifepristone with misoprostol and mifepristone with PG05--a multicentre randomized clinical trial in China.
    Sang GW; Weng LJ; Shao QX; Du MK; Wu XZ; Lu YL; Cheng LN
    Contraception; 1994 Dec; 50(6):501-10. PubMed ID: 7705093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical versus surgical methods for first trimester termination of pregnancy.
    Say L; Kulier R; Gülmezoglu M; Campana A
    Cochrane Database Syst Rev; 2002; (4):CD003037. PubMed ID: 12519584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of methotrexate and misoprostol for early abortion.
    Ozeren S; Corakçi A; Yücesoy I; Mercan R; Arslan A; Erhan G
    Gynecol Obstet Invest; 1997; 44(2):112-4. PubMed ID: 9286724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety, efficacy and acceptability of outpatient mifepristone-misoprostol medical abortion through 70 days since last menstrual period in public sector facilities in Mexico City.
    Sanhueza Smith P; Peña M; Dzuba IG; García Martinez ML; Aranguré Peraza AG; Bousiéguez M; Shochet T; Winikoff B
    Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):75-82. PubMed ID: 25702071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparing abortion induced with methotrexate and misoprostol to methotrexate alone.
    Wiebe ER
    Contraception; 1999 Jan; 59(1):7-10. PubMed ID: 10342080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.